115 related articles for article (PubMed ID: 38874235)
1. Role of histogram features on arterial spin labeling perfusion magnetic resonance imaging in identifying isocitrate dehydrogenase genotypes and glioma malignancies.
Su C; Peng C; Sun Y; Damen FC; Jiang R; Xie C; Cai K
Turk Neurosurg; 2023 May; ():. PubMed ID: 38874235
[TBL] [Abstract][Full Text] [Related]
2. Histogram analysis of quantitative susceptibility mapping and apparent diffusion coefficient for identifying isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas.
Sun Y; Yang Z; Deng K; Geng Y; Hu X; Song Y; Jiang R
Quant Imaging Med Surg; 2023 Dec; 13(12):8681-8693. PubMed ID: 38106258
[TBL] [Abstract][Full Text] [Related]
3. Whole-tumor histogram analysis of synthetic magnetic resonance imaging predicts isocitrate dehydrogenase mutation status in gliomas.
Ge X; Gan T; Yang Z; Liu G; Hu W; Ma W; Bai Y; Xiong Y; Li M; Zhao J; Zhou L; Li J; Li D; Wang X; Zhang J
Quant Imaging Med Surg; 2024 Mar; 14(3):2225-2239. PubMed ID: 38545061
[TBL] [Abstract][Full Text] [Related]
4. [Apparent Diffusion Coefficient Histogram Analysis:Differentiation of Genetic Subtypes of Diffuse Lower-grade Gliomas].
Liu D; Xu JM; Liao HF; Wen M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Aug; 42(4):444-451. PubMed ID: 32895095
[No Abstract] [Full Text] [Related]
5. Non-Invasive Estimation of Glioma
Hu Y; Chen Y; Wang J; Kang JJ; Shen DD; Jia ZZ
Front Oncol; 2020; 10():593102. PubMed ID: 33425744
[TBL] [Abstract][Full Text] [Related]
6. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of ADC histogram and direct ADC measurements for coexisting isocitrate dehydrogenase mutation and O6-methylguanine-DNA methyltransferase promoter methylation in glioma.
Xie Z; Li J; Zhang Y; Zhou R; Zhang H; Duan C; Liu S; Niu L; Zhao J; Liu Y; Song S; Liu X
Front Neurosci; 2022; 16():1099019. PubMed ID: 36711137
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Study of 2 Different Segmentation Methods of ADC Histogram for Differentiation Genetic Subtypes in Lower-Grade Diffuse Gliomas.
Liu D; Gao SX; Liao HF; Xu JM; Wen M
Biomed Res Int; 2020; 2020():9549361. PubMed ID: 33062706
[TBL] [Abstract][Full Text] [Related]
9. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
[TBL] [Abstract][Full Text] [Related]
10. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.
Yang X; Lin Y; Xing Z; She D; Su Y; Cao D
Acta Radiol; 2021 Dec; 62(12):1657-1665. PubMed ID: 33222488
[TBL] [Abstract][Full Text] [Related]
11. Preoperative and Noninvasive Prediction of Gliomas Histopathological Grades and IDH Molecular Types Using Multiple MRI Characteristics.
Du N; Zhou X; Mao R; Shu W; Xiao L; Ye Y; Xu X; Shen Y; Lin G; Fang X; Li S
Front Oncol; 2022; 12():873839. PubMed ID: 35712483
[TBL] [Abstract][Full Text] [Related]
12. Combined texture analysis of dynamic contrast-enhanced MRI with histogram analysis of diffusion kurtosis imaging for predicting IDH mutational status in gliomas.
Pan T; Su CQ; Tang WT; Lin J; Lu SS; Hong XN
Acta Radiol; 2023 Sep; 64(9):2552-2560. PubMed ID: 37331987
[TBL] [Abstract][Full Text] [Related]
13. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
[TBL] [Abstract][Full Text] [Related]
15. DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival.
Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Wang MZ; Zhang H; Liang LH; Feng YN; Yang JH
Acad Radiol; 2020 Dec; 27(12):e263-e271. PubMed ID: 31983532
[TBL] [Abstract][Full Text] [Related]
16. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.
Yoo RE; Yun TJ; Hwang I; Hong EK; Kang KM; Choi SH; Park CK; Won JK; Kim JH; Sohn CH
Eur Radiol; 2020 Feb; 30(2):1202-1211. PubMed ID: 31468161
[TBL] [Abstract][Full Text] [Related]
17. Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.
Brendle C; Hempel JM; Schittenhelm J; Skardelly M; Tabatabai G; Bender B; Ernemann U; Klose U
Clin Neuroradiol; 2018 Sep; 28(3):421-428. PubMed ID: 28488024
[TBL] [Abstract][Full Text] [Related]
18. Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?
Yan LF; Sun YZ; Zhao SS; Hu YC; Han Y; Li G; Zhang X; Tian Q; Liu ZC; Yang Y; Nan HY; Yu Y; Sun Q; Zhang J; Chen P; Hu B; Li F; Han TH; Wang W; Cui GB
Cancer Manag Res; 2019; 11():9989-10000. PubMed ID: 31819632
[TBL] [Abstract][Full Text] [Related]
19. Noninvasively evaluating the grade and IDH mutation status of gliomas by using mono-exponential, bi-exponential diffusion-weighted imaging and three-dimensional pseudo-continuous arterial spin labeling.
Guo D; Jiang B
Eur J Radiol; 2023 Mar; 160():110721. PubMed ID: 36738600
[TBL] [Abstract][Full Text] [Related]
20. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy.
Seo M; Choi Y; Soo Lee Y; Ahn KJ; Kim BS; Park JS; Jeon SS
Eur J Radiol; 2023 Aug; 165():110888. PubMed ID: 37257338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]